Treatment of diabetes with copper binding compounds
OwnerJohn Richard Baker, Garth J. S. Cooperinventors
Life of this patent
Estimating the term…
Abstract
Novel methods of treating a patient for diseases, disorders, and conditions including diabetes mellitus, comprising administering, for example, copper binding compounds.
Claims50
A method of treating a human for diabetes, the method comprising administering to said human a composition comprising a therapeutically effective amount of a pharmaceutically acceptable cupric binding agent selected from the group consisting of triethylenetetramine dihydrochloride, penicillamine, sar, diamsar, and o-phenanthroline.
A method of treating a human for diabetes, the method comprising administering to said human a composition comprising a therapeutically effective amount of a pharmaceutically acceptable oxidized copper binding agent.
A method of treating one or more long-term complications of diabetes in a human suffering therefrom, the method comprising administering a composition consisting essentially of a cupric binding agent in an amount effective to ameliorate one or more of said conditions.
A method for minimizing or reducing tissue damage associated with diabetes mellitus in a human, which comprises the prophylactic administration to a human of a therapeutically effective amount of a cupric binding agent.
A method of treating one or more long-term complications of diabetes in a human suffering therefrom, the method comprising administering a composition consisting essentially of a compound that can bind or chelate oxidized, copper in an amount effective to ameliorate one or more of said conditions.
A method for minimizing or reducing tissue damage associated with diabetes mellitus in a human, which comprises the prophylactic administration to a human of a therapeutically effective amount of a compound that can bind or chelate oxidized copper.
A method of treating one or more long-term complications of diabetes in a human suffering therefrom, the method comprising forming a cupric complex within the human by administering a composition consisting essentially of an effective amount of a copper binding agent.
A method of treating one or more long-term complications of diabetes in a human suffering therefrom, the method comprising forming an oxidized copper complex within the human by administering a composition consisting essentially of an effective amount of a copper binding agent.
A method for minimizing or reducing tissue damage associated with diabetes mellitus in a human, the method comprising forming a cupric complex within the human by prophylactically administering an effective amount of a copper binding agent.
A method for minimizing or reducing tissue damage associated with diabetes mellitus in a human, the method comprising forming an oxidized copper complex within the human by prophylactically administering an effective amount of a copper binding agent.
Dependencies are inferred from the claim text.